Tech stocks tumbled as Chinese AI startup DeepSeek's advances raised fears of intensified competition, shaking investor ...

H.C. Wainwright revised its price target for Personalis (NASDAQ:PSNL) shares, dropping it to $8.00 from the previous $11.00. Despite this reduction, the firm maintained a Buy rating on the company's ...

Everything to Know about Macro and Markets Stocks clocked in their second consecutive weekly gain and the best start to a ...

Shares of Moderna (NASDAQ: MRNA) zoomed as much as 33.3% higher this week, according to data from S&P Global Market ...

The Stargate Project, a $500B initiative focused on artificial intelligence, lifted AI-driven biotech stocks this week while boosting an unlikely winner, Metagenomi (NASDAQ:MGX), which benefitted from ...

Based on its share price, down 75% in the last three years, it's easy to write off Moderna (NASDAQ: MRNA) as a biotech ...

The press release also contained forward-looking statements, cautioning that these are not guarantees and are subject to risks, uncertainties, and other factors that could cause actual results to ...

Moderna (MRNA) stock gained in the premarket after the company received a tender to supply its COVID-19 vaccine in the EU, ...

We recently published a list of These 10 Firms Were Thursday’s Top Performers. In this article, we are going to take a look ...

We recently compiled a list of the These 10 Companies Led Gains on Wednesday. In this article, we are going to take a look at ...

Key Takeaways The S&P 500 advanced 0.6% on Wednesday, Jan. 22, 2025, following the announcement of major AI investments and a ...

Moderna , Inc. (NASDAQ:MRNA) shares surged 14% following remarks by Oracle (NYSE:ORCL) Chairman Larry Ellison on the transformative potential of artificial intelligence (AI) in healthcare, ...